NF-kappaB and the innate immune response in the respiratory distress syndrome of the newborn: commentary on the article by Cheah et al. on page 616.
Chatila
Talal A
TA
Division of Neonatology, The David Geffen School of Medicine at the University of California at Los Angeles, MDCC 12-430; mail code 175217, 10833 Le Conte Avenue, Los Angeles CA 90095-1752. tchatila@mednet.ucla.edu
Smith
Jeffery B
JB
D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007107:Immune System; D007231:Infant, Newborn; D007249:Inflammation; D016328:NF-kappa B / Q000378:metabolism / Q000502:physiology*; D011485:Protein Binding; D012127:Respiratory Distress Syndrome, Newborn / Q000276:immunology* / Q000378:metabolism* / Q000628:therapy; D013501:Surface-Active Agents / Q000627:therapeutic use
D016207:Cytokines; D016328:NF-kappa B; D013501:Surface-Active Agents